'White matter lesion' mapping tool identifies early signs of dementia

October 27, 2020

A new tool for analyzing tissue damage seen on MRI brain scans can detect with more than 70 percent accuracy early signs of cognitive decline, new research shows.

The findings by imaging specialists at NYU Grossman School of Medicine center on small bright spots on scans called white matter hyperintensities. Increased numbers and size of the intense-white spots seen on the mostly gray images of the brain have long been linked to memory loss and emotional problems, especially as people age.

More spots on MRI and their occurrence in the center of the brain have also been shown to correlate with the worsening of dementia and other brain-damaging conditions, such as stroke and depression, say the study authors. The spots represent fluid-filled holes in the brain, lesions that are believed to develop from the breakdown of blood vessels that nourish nerve cells.

Current methods for grading white matter lesions rely on little more than the "trained eye," researchers say, using an imprecise three-point scale, with a score of 1 meaning minimal white spots, while grades of 2 or 3 suggest more significant disease. The new tool was developed, researchers say, in an effort to provide a uniform, objective method for calculating the spots' volume and location in the brain.

In the new study, publishing in the journal Academic Radiology online Oct. 27, the NYU Langone team randomly selected 72 MRI scans from a national database of elderly people, the Alzheimer's Disease Neuroimaging Initiative. Equal numbers were from elderly men and women, mostly white and over age 70, with normal brain function, or showing some mild cognitive decline, or suffering from severe dementia.

Using the latest MRI techniques for accurate mapping of the brain's surface, the team then used computer software to calculate the precise position and volume measurements for all observed white matter lesions. Specifically, they tabulated volumes, which are three-dimensional measurements in liters, based on each lesion's distance from both side surfaces of the brain, with normal ranges between 0 milliliters (no lesions seen) and 60 milliliters (some lesions). Volumes greater than 100 milliliters indicated severe disease. When researchers cross-checked their measurements, they found that seven out of 10 calculations correctly matched the patient's actual diagnosis.

"Amounts of white matter lesions above the normal range should serve as an early warning sign for patients and physicians," says study lead researcher Jingyun "Josh" Chen, PhD, a research assistant professor in the Department of Neurology at NYU Langone Health.

Chen cautions that the white matter brain measures alone are not sufficient to certify a finding of early dementia, but should be considered along with other factors, including a history of brain injury, memory loss, and hypertension, as clear features of cognitive decline and/or other brain and blood vessel diseases.

"Our new calculator for properly sizing white matter hyperintensities, which we call bilateral distancing, offers radiologists and other clinicians an additional standardized test for assessing these lesions in the brain, well before severe dementia or stroke damage," says study senior investigator Yulin Ge, MD, a professor in the Department of Radiology at NYU Langone.

With a standardized tracking and measuring tool, says Chen, it is now possible to monitor the growth of white matter lesions relative to that of other tau and beta-amyloid proteins also believed to be potential causes of dementia and Alzheimer's disease. The buildup of either substance could also prove or disprove one or more of the theories about what biological processes actually lead to various forms of dementia.

Chen says the team plans to broaden and test their measuring tool on an additional 1,495 brain scans to include a more diverse group from the same database.

Physicians can access the tool, which is available without cost online at -end-
Funding support for the study was provided by National Institutes of Health grants RF1 NS110041, U24 EB028980, R56 AG060822, R01 EB025133, P30 AG008051, and P41 EB017183. Additional funding support came from Alzheimer's Disease Association grant AARG-17-533484.

Besides Chen and Ge, other NYU Langone researchers involved in this study are Artem Mikheev, PhD; Han Yu, MA; Matthew Gruen; and Henry Rusinek, PhD.

NYU Langone Health / NYU School of Medicine

Related Dementia Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

The long road to dementia
Alzheimer's disease develops over decades. It begins with a fatal chain reaction in which masses of misfolded beta-amyloid proteins are produced that in the end literally flood the brain.

Why people with dementia go missing
People with dementia are more likely to go missing in areas where road networks are dense, complicated and disordered - according to new research from the University of East Anglia.

PTSD may double risk of dementia
People who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life, according to a new study by UCL researchers, published in the British Journal of Psychiatry.

Dementia education
School-based dementia education could deliver much needed empathy and understanding for older generations as new research from the University of South Australia shows it can significantly improve dementia knowledge and awareness among younger generations.

Building dementia friendly churches
A project to help church communities become more 'dementia friendly' has had a significant impact across the country.

A "feeling" for dementia?
A research team led by the DZNE concludes that personal perception can be an important indicator for the early detection of Alzheimer's disease.

New biomarker for dementia diagnosis
Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.

Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.

Read More: Dementia News and Dementia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.